Country-Of-Origin Labeling Would Add Costs But No Consumer Benefit – CRN
• By Dan Schiff
Requiring country-of-origin labeling for dietary supplements would be redundant with good manufacturing practices and could raise prices without benefiting consumers, according to the Council for Responsible Nutrition
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
The UK’s research-based pharma industry and medical research charities have set out clear action points to drive greater diversity and inclusion in clinical trials.
Blenrep, GSK’s multiple myeloma therapy, faced a major setback when it was withdrawn from the market in 2022. The drug has since made a return as a second-line therapy, and is on track to being reimbursed in England.